Press Release

Small Volume Parenteral Market to Grow with a CAGR of 7.10% through 2028

Technological advancements and the demand for home healthcare is expected to drive the Global Small Volume Parenteral Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Small Volume Parenteral Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Small Volume Parenteral Market stood at USD 167.97 billion in 2022 and is anticipated to grow with a CAGR of 7.10% in the forecast period, 2024-2028. This can be attributed to growing global healthcare expenditure. Governments and private entities around the world are increasing their healthcare expenditure to meet the growing demand for medical services. This financial commitment to the healthcare sector is fostering the growth of the SVP market, as healthcare facilities have more resources to invest in these essential intravenous solutions.

Furthermore, quality control and traceability are becoming paramount in the pharmaceutical industry, and the SVP market is no exception. Advancements in tracking technologies, such as blockchain and RFID, are being integrated to improve the traceability of SVP products from manufacturing to patient administration. These technologies enhance patient safety and streamline regulatory compliance.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Small Volume Parenteral Market

 

The demand for small-volume parenteral (SVP) products has experienced a steady increase, primarily driven by the rising incidence of chronic diseases and the necessity for intravenous medications within healthcare facilities. The expanding elderly population, particularly in developed nations, has led to a heightened demand for medical interventions. SVPs are preferred for their ease of administration and precise dosing, factors contributing to their growing market demand. Additionally, advancements in pharmaceutical manufacturing processes and packaging technologies have enhanced the safety, quality, and shelf life of SVPs, making them more dependable for healthcare providers and patients. These improvements also enable more accurate and consistent SVP production, ensuring that each dose contains the intended amount of active pharmaceutical ingredients. This heightened precision in dosing positively influences treatment outcomes and patient safety, thereby contributing to market growth.

Furthermore, the growth of biopharmaceuticals and personalized medicine has fueled the demand for SVPs as they enable the safe and accurate delivery of these specialized medications. Moreover, the increasing elderly population plays a significant role in driving the global market's growth.

According to a United Nations report, the global population of individuals aged 60 and above is projected to increase significantly, from 962 million in 2017 to 2.1 billion by 2050 and 3.1 billion by 2100. This demographic shift results in a higher prevalence of chronic diseases and conditions that necessitate ongoing medical treatment, often involving injectable medications and fluids. Elderly individuals typically face a higher likelihood of hospitalization and may require specialized care that includes SVP products for various therapies. This demographic trend not only elevates the overall demand for SVP products but also encourages innovation in the development of targeted therapies and delivery systems tailored to the unique healthcare needs of older adults.

The Global Small Volume Parenteral Market is segmented into form, type, packaging, indication, regional distribution, and company.

Based on its packaging, Ampoules were the prevailing choice, securing the highest revenue share in 2022. This dominance is projected to persist throughout the forecast period. Ampoules are favored for their precise and hermetically sealed packaging, guaranteeing accurate dosage administration and minimizing the potential for contamination. Their single-use design contributes to patient safety by preventing cross-contamination.

Ampoules also align with the increasing demand for convenient, ready-to-administer drug delivery solutions, particularly in emergency and clinical settings. These factors, combined with the global emphasis on sterile packaging and efficient drug delivery, are propelling the growth of this segment.

Based on indication, the "others" segment emerged as the dominant category within the market in 2022. This segment primarily encompasses conditions such as Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatments, and various other health ailments. Patients undergoing intensive treatments, including radiation therapy, immunotherapy, and medication, often experience severe nutritional deficiencies due to metabolic changes, loss of appetite, and alterations in their immune system. Notably, significant weight loss is a prominent physical change observed in such patients. Consequently, Single-Volume Parenteral (SVP) solutions are recommended for these patients to help restore their nutritional balance. Thus, the increasing prevalence of various conditions where SVPs play a crucial role in addressing nutritional imbalances is propelling the growth of this segment.

However, it is anticipated that the dysphagia segment will experience the most rapid growth during the forecast period, primarily due to the high prevalence of this condition. According to a 2022 article published in MDPI, the prevalence of dysphagia among elderly nursing home residents was approximately 58.69%, as determined by the Standard Swallowing Assessment (SSA). Additionally, the prevalence of dysphagia among the elderly residing in the community was estimated to be around 30.52%. Dysphagia often leads to complications such as aspiration pneumonia, necessitating the use of parenteral nutrition, thereby positively influencing market growth.

Major companies operating in Global Small Volume Parenteral Market are:

  • BML Parenteral Drugs
  • Rusoma Laboratories Pvt Ltd
  • B Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Sichuan Kelun Pharmaceutical Co Ltd

 

Download Free Sample Report

Customers can also request for 10% free customization on this report

 

“The global Small Volume Parenteral market is experiencing a transformative phase, driven by the convergence of the emerging trends. Personalized medication compounding, technological advancements, sustainability initiatives, the growth of home healthcare, specialized formulations, global expansion, and enhanced quality control are all shaping the future of the SVP market. As healthcare continues to advance and patient-centric care becomes the norm, SVP solutions are set to play an even more pivotal role in the administration of intravenous medications, offering precise and efficient treatment options to patients around the world. Manufacturers and suppliers in the SVP market must remain agile, adapting to these trends to meet the evolving needs of the healthcare industry,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Global Small Volume Parenteral Market By Form (Liquid, Dry), By Type (Single-dose, Multiple-dose), By Packaging (Ampoules, Vials, Pre-filled Syringes, Cartridges, Bottles, Others), By Indication (Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder/Diarrhea, Diabetes, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Small Volume Parenteral Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Small Volume Parenteral Market.


Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com

Relevant News